GLPwatch
Zepbound for Opioid use disorder
tirzepatide · Investigational / off-label
Last updated 2026-05-28 15:46 UTCZepbound (tirzepatide) is not FDA-approved for opioid use disorder, and any use for this condition is off-label or investigational. The listed research discusses tirzepatide in the context of obesity-related diseases and addictions but does not provide specific findings related to opioid use disorder.
AI summary of the sources below.
| Drug | Zepbound (tirzepatide) |
|---|---|
| Condition | Opioid use disorder |
| Approval status | Investigational / off-label |
| Research papers | 1 |
Zepbound is not FDA-approved for opioid use disorder; the research below reflects investigational or off-label study only.